European Pharmacopoeia Issue 13.1 Implementation Requirements

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published European Pharmacopoeia (Ph. Eur.) Issue 13.1, introducing updated and revised monographs, analytical requirements, and quality standards impacting medicinal products and active substances. The updated pharmacopoeial requirements affect analytical method validation, product specifications, GMP documentation, and quality control procedures. Companies are expected to assess the impact of revised texts on existing validation packages, regulatory documentation, and manufacturing quality systems ahead of the mandatory enforcement date.